Showing results (1001-1010 of 10,077) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|November 27, 2012
Redox control of cardiovascular homeostasis by angiotensin IICaroline Sunggip, Naoyuki Kitajima, Motohiro NishidaCurrent Pharmaceutical Design|November 27, 2012
Angiotensin II blockade and renal protectionHiroyuki Kobori, Hirohito Mori, Tsutomu Masaki, et al.Current Pharmaceutical Design|November 27, 2012
The physiology and pathophysiology of a novel angiotensin receptor-binding protein ATRAP/AgtrapKouichi Tamura, Hiromichi Wakui, Akinobu Maeda, et al.Current Pharmaceutical Design|November 27, 2012
Potential effect of angiotensin II receptor blockade in adipose tissue and boneHironori Nakagami, Mariana Kiomy Osako, Ryuichi MorishitaCurrent Pharmaceutical Design|November 27, 2012
Non-ACE pathway-induced angiotensin II productionYoshinari Uehara, Shin-ichiro Miura, Eiji Yahiro, et al.Current Pharmaceutical Design|November 27, 2012
Chymase inhibitorsEiji Yahiro, Shin-ichiro Miura, Satoshi Imaizumi, et al.Current Pharmaceutical Design|November 23, 2012
The role of protonation states in ligand-receptor recognition and bindingMarharyta Petukh, Shannon Stefl, Emil AlexovCurrent Pharmaceutical Design|November 23, 2012
Nucleotide binding affects intrinsic dynamics and structural communication in Ras GTPasesFrancesca Fanelli, Francesco RaimondiCurrent Pharmaceutical Design|November 23, 2012
Effects of the protonation state of the catalytic residues and ligands upon binding and recognition in targeted proteins of HIV-1 and influenza virusesNadtanet Nunthaboot, Thanyada Rungrotmongkol, Ornjira Aruksakunwong, et al.Current Pharmaceutical Design|November 23, 2012
Calculation methods for the enhancement of pharmaceutical properties in small molecules: estimating the cationic pKaAnn R Hermone, Rick GussioPageof 1,008